Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 712836 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming patent expiries limit market growth' returned 2 results - Page 1 of 1

 FEATURED RESULTS
Drug Delivery in Cancer - Technologies, Markets and Companies

Cancer Diagnostic Testing World Markets

Antibody Drug Target Atlas in Oncology

DNA Repair in Cancer Therapy. Molecular Targets and Clinical...

Aurora Kinase inhibitors - The dawn of a new approach to cancer


  Sort by   
  Sorted by Rank Top-Bottom

Commercial Insight: Cytotoxic Therapies - Drug launches in rare indications to offset the decline in cytotoxic sales  
Datamonitor, July 2010, Pages: 114
of the marketed cytotoxic therapy cancer brands in the seven major markets over the period 2009 to 2019 -Acquire a detailed account of cytotoxic therapy cancer brand dynamics and the events that drive and limit


Commercial Insight: Cancer Targeted Therapies and Immunotherapies -Top monoclonal antibody brands will resist competitive pressures through to 2019  
Datamonitor, Aug 2010, Pages: 132
and growth through to 2019 Indication expansions will offset patent expiries in the cancer targeted therapies and immunotherapies market The five major European markets and Japan will grow at a higher rate


Results:  First -   Prev -   1 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds